Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 11th January 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New study may improve cancer treatment for dogs
The finding could lead to the development of a non-invasive prognostic test.
Finding could be used to assess how best to treat dogs with mast cell tumours

Scientists have successfully identified genetic changes in canine mast cell tumours that are linked to the spread of tumours.

The finding, made by vets at the Animal Health Trust and the University of Liverpool, could one day be used to determine how best to treat dogs with mast cell tumours, and may also promote the development of new treatments.

Scientists also say the finding could lead to the development of a non-invasive prognostic test which would tell vets if a cutaneous mast cell tumour is likely to spread, and therefore if chemotherapy is appropriate.

The availability of such a test would help ensure dogs receive the right cancer treatment and would reduce the number of dogs who receive treatment that is not beneficial. The findings have been published in the journal PLoS One.

“The findings of the research study is the result of many years work and are important because so many dogs are affected by cutaneous mast cell tumours,” explained study leader Dr Mike Starkey. “Cancer affects one in four dogs and research is the only way to fight cancer.

“I’m hugely grateful to everyone who has supported my team and this research to-date, and I believe this is a really exciting time as we can begin to see how our work can improve the outcome for dogs with cancer.”
 
He continued: “We spent a lot of time collecting a suitable group of mast cell tumour samples to allow us to study tumour spread, but we are very excited about the results and their potential relevance to dog health.”

The next step of the research is to further validate the accuracy of the results by conducting a larger retrospective study. To do this, the scientists will require the help of vets all over the country to collect the necessary tumour biopsies.

It is hoped the study will be completed within two years and work to develop the test could begin soon as 2021.

 

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.